HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.

Abstract
Patients with congenital disorder of glycosylation (CDG), type Ib (MPI-CDG or CDG-Ib) have mutations in phosphomannose isomerase (MPI) that impair glycosylation and lead to stunted growth, liver dysfunction, coagulopathy, hypoglycemia, and intestinal abnormalities. Mannose supplements correct hypoglycosylation and most symptoms by providing mannose-6-P (Man-6-P) via hexokinase. We generated viable Mpi hypomorphic mice with residual enzymatic activity comparable to that of patients, but surprisingly, these mice appeared completely normal except for modest (~15%) embryonic lethality. To overcome this lethality, pregnant dams were provided 1-2% mannose in their drinking water. However, mannose further reduced litter size and survival to weaning by 40 and 66%, respectively. Moreover, ~50% of survivors developed eye defects beginning around midgestation. Mannose started at birth also led to eye defects but had no effect when started after eye development was complete. Man-6-P and related metabolites accumulated in the affected adult eye and in developing embryos and placentas. Our results demonstrate that disturbing mannose metabolic flux in mice, especially during embryonic development, induces a highly specific, unanticipated pathological state. It is unknown whether mannose is harmful to human fetuses during gestation; however, mothers who are at risk for having MPI-CDG children and who consume mannose during pregnancy hoping to benefit an affected fetus in utero should be cautious.
AuthorsVandana Sharma, Jonamani Nayak, Charles DeRossi, Adriana Charbono, Mie Ichikawa, Bobby G Ng, Erika Grajales-Esquivel, Anand Srivastava, Ling Wang, Ping He, David A Scott, Joseph Russell, Emily Contreras, Cherise M Guess, Stan Krajewski, Katia Del Rio-Tsonis, Hudson H Freeze
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 28 Issue 4 Pg. 1854-69 (Apr 2014) ISSN: 1530-6860 [Electronic] United States
PMID24421398 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Mannosephosphates
  • mannose-6-phosphate
  • Mannose-6-Phosphate Isomerase
  • Mannose
Topics
  • Animals
  • Blindness (etiology, genetics, metabolism)
  • Blotting, Western
  • Cells, Cultured
  • Congenital Disorders of Glycosylation (genetics, metabolism)
  • Dietary Supplements (toxicity)
  • Embryo, Mammalian (cytology, drug effects, metabolism)
  • Eye (embryology, growth & development, metabolism)
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Mannose (blood, metabolism, toxicity)
  • Mannose-6-Phosphate Isomerase (genetics, metabolism)
  • Mannosephosphates (metabolism)
  • Mice
  • Mice, 129 Strain
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Placenta (drug effects, embryology, metabolism)
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: